Abbott Laboratories (ABT) Business News

Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
9:14 AM | Wednesday | Aug 12, 2026 PRNewsWire

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

News Thumbnail
9:00 AM | Tuesday | Aug 11, 2026 PRNewsWire

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

News Thumbnail
8:00 AM | Monday | Jul 27, 2026 GlobeNewsWire

FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

News Thumbnail
7:30 AM | Thursday | Jul 16, 2026 PRNewsWire

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

News Thumbnail
9:00 AM | Thursday | Jun 25, 2026 PRNewsWire

Abbott hosts conference call for second-quarter earnings

News Thumbnail
8:30 AM | Wednesday | Jun 24, 2026 PRNewsWire

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

News Thumbnail
12:00 PM | Monday | Jun 22, 2026 PRNewsWire

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

News Thumbnail
9:00 AM | Monday | Jun 8, 2026 PRNewsWire

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

News Thumbnail
9:00 AM | Saturday | Jun 6, 2026 PRNewsWire

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

News Thumbnail
9:00 AM | Wednesday | May 27, 2026 PRNewsWire

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

News Thumbnail
news photo
Loading...

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national blood crisis after donations dropped to a four-year summer low, threatening the availability of lifesaving blood for patients across the country Abbott and the Big Ten urge people to donate blood now and will count those early donations toward the competition, which officially kicks off Aug. 26 Anyone can donate blood anywhere in the U.S. between Aug. 12-Dec.
4 and log their donation starting Aug. 26 for a Big Ten school at BigTen.org/Abbott or by texting GIVEBLOOD to 222688 (ABBOTT) and select an exclusive, limited-edition T-shirt* while supplies last The movement aims to fuel a new generation of blood donors at a time when 2.5 million donations — nearly a quarter of all donations — come from people over the age of 65 ABBOTT PARK, Ill. and ROSEMONT, Ill.

Read full article redirect
9:14 AM | Wednesday | Aug 12, 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

PRNewsWire

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national blood crisis after donations dropped to a four-year summer low, threatening the availability of lifesaving blood for patients across the country Abbott and the Big Ten urge people to donate blood now and will count those early donations toward the competition, which officially kicks off Aug. 26 Anyone can donate blood anywhere in the U.S. between Aug. 12-Dec.
4 and log their donation starting Aug. 26 for a Big Ten school at BigTen.org/Abbott or by texting GIVEBLOOD to 222688 (ABBOTT) and select an exclusive, limited-edition T-shirt* while supplies... Read more

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Aug 11, 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

PRNewsWire

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future Lingo product features Lingo, Abbott's over-the-counter continuous glucose monitor (CGM), helps people understand the impact of nutrition, activity, sleep and stress on their glucose so they can make meaningful lifestyle changes ABBOTT PARK, Ill., Aug. 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a first-of-its-kind partnership with Google Health to redefine how people understand and manage their health.

Read full article arrow
News Thumbnail
8:00 AM | Monday | Jul 27, 2026

FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

GlobeNewsWire

– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening – – Medicare coverage and American Cancer Society guidance support broader access to blood-based colorectal cancer screening – BRISBANE, Calif. and ABBOTT PARK, Ill.

Read full article arrow
News Thumbnail
7:30 AM | Thursday | Jul 16, 2026

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

PRNewsWire

Second-quarter reported sales growth of 13.0 percent; comparable sales growth of 4.8 percent Second-quarter GAAP diluted EPS of $0.53; adjusted diluted EPS of $1.31 Abbott reaffirms full-year 2026 comparable sales growth guidance of 6.
5% to 7.5%¹ Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.
58 Abbott returned $2.1 billion to shareholders in the second quarter in the form of dividends and share repurchases ABBOTT PARK, Ill., July 16, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2026.

Read full article arrow
News Thumbnail
9:00 AM | Thursday | Jun 25, 2026

Abbott hosts conference call for second-quarter earnings

PRNewsWire

ABBOTT PARK, Ill., June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.

Read full article arrow
News Thumbnail
8:30 AM | Wednesday | Jun 24, 2026

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

PRNewsWire

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ -- ALZpath Inc.,  the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ALZpath's proprietary phosphorylated Tau 217 (pTau217) antibody into the development of an in vitro diagnostic (IVD) test for Alzheimer's disease.

Read full article arrow
News Thumbnail
12:00 PM | Monday | Jun 22, 2026

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

PRNewsWire

Despite optimism about parenthood, unrealistic online portrayals are adding pressure for today's young parents Through the new "Love Without Measure" initiative, Similac is standing with parents in promoting more authentic portrayals of parenthood and pushing back on comparison culture ABBOTT PARK, Ill., June 22, 2026 /PRNewswire/ -- Parenthood is widely anticipated as one of life's most fulfilling journeys, yet for today's new parents – especially Gen Z – that excitement is often met with feelings of pressure and judgment and amplified by picture-perfect social media portrayals.

Read full article arrow
News Thumbnail
9:00 AM | Monday | Jun 8, 2026

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

PRNewsWire

Study at ADA's Scientific Sessions shows participants in Abbott's Healthy Food Rx program combined with health coaching had significant health improvements Abbott's Healthy Food Rx program is a Food is Medicine initiative delivering recipe-based food boxes and nutrition education to people living with diabetes NEW ORLEANS, June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86th Scientific Sessions showed that adults living with type 2 diabetes participating in Abbott's (NYSE: ABT) Healthy Food Rx "Food is Medicine" program, paired with community health worker–led coaching, experienced major improvements in healthy eating, physical activity, diabetes self-management, food insecurity and self-reported physical and mental health. Conducted with the Public Health Institute Center for Wellness and Nutrition (PHI CWN), the Asian Pacific Self-Development and Residential Association (APSARA) and the Emergency... Read more

Read full article arrow
News Thumbnail
9:00 AM | Saturday | Jun 6, 2026

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

PRNewsWire

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect early Ketone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and delays in intervention Nearly 60% of pediatric hospitalizations for Type 1 diabetes in the U.S. are associated with DKA1 ABBOTT PARK, Ill., June 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected health concern for people living with both Type 1 and Type 2 diabetes.

Read full article arrow
News Thumbnail
9:00 AM | Wednesday | May 27, 2026

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

PRNewsWire

First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to diabetic ketoacidosis, a serious health condition for people with diabetes Integrates with the Libre digital health ecosystem, allowing people to share glucose and ketone data with caregivers and healthcare providers Designed for compatibility with leading automated insulin delivery (AID) systems ABBOTT PARK, Ill., May 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual glucose‑ketone sensing technology for people with diabetes.

Read full article arrow
News Thumbnail